Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Occupational and Environmental Medicine|August 16, 2019
Occupational risk of salmonellosis and campylobacteriosis: a nationwide population-based registry studyJanneke W Duijster, Eelco Franz, Jacques J C Neefjes, et al.Iscience|July 19, 2021
Spatially resolved sampling for untargeted metabolomics: A new tool for salivomicsAlessio Ciurli, Maximiliam Liebl, Rico J E Derks, et al.Expert Review of Anticancer Therapy|March 5, 2016
A catalogue of treatment and technologies for malignant pleural mesotheliomaLaurel M Schunselaar, Josine M M F Quispel-Janssen, Jacques J C Neefjes, et al.Natural Product Reports|December 24, 2021
Anthracyclines: biosynthesis, engineering and clinical applicationsMandy B Hulst, Thadee Grocholski, Jacques J C Neefjes, et al.European Journal of Cancer (Oxford, England : 1990)|August 3, 2020
A brief report on combination chemotherapy and anti-programmed death (ligand) 1 treatment in small-cell lung cancer: Did we choose the optimal chemotherapy backbone?Joanne M Mankor, Fenneke Zwierenga, Daphne W Dumoulin, et al.Epidemiology and Infection|February 8, 2021
Association between <i>Salmonella</i> infection and colon cancer: a nationwide registry-based cohort studyJanneke W Duijster, Jørgen V Hansen, Eelco Franz, et al.Journal of Medicinal Chemistry|August 1, 2024
Novel <i>N,N</i>-Dimethyl-idarubicin Analogues Are Effective Cytotoxic Agents for ABCB1-Overexpressing, Doxorubicin-Resistant CellsMerle A van Gelder, Yufeng Li, Dennis P A Wander, et al.Nature Communications|November 4, 2020
A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol exportDick J H van den Boomen, Agata Sienkiewicz, Ilana Berlin, et al.Frontiers in Bioengineering and Biotechnology|March 14, 2024
Metabolic engineering of <i>Streptomyces peucetius</i> for biosynthesis of <i>N,N</i>-dimethylated anthracyclinesMandy B Hulst, Le Zhang, Helga U van der Heul, et al.Journal of the American Chemical Society|April 11, 2020
Immunoproteasome Inhibitor-Doxorubicin Conjugates Target Multiple Myeloma Cells and Release Doxorubicin upon Low-Dose Photon IrradiationElmer Maurits, Michel J van de Graaff, Santina Maiorana, et al.Pageof 2